Argitalpenak (253) Ikertzaileren baten partaidetza izan duten argitalpenak

2024

  1. CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

    Cancer Letters, Vol. 588

  2. Endothelial-to-Mesenchymal Transition in an Hereditary Hemorrhagic Telangiectasia-like Pediatric Case of Multiple Pulmonary Arteriovenous Malformations

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  3. Molecular and Cellular Characterization of Primary Endothelial Cells from a Familial Cavernomatosis Patient

    International Journal of Molecular Sciences, Vol. 25, Núm. 7

  4. PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients

    Molecular Oncology

  5. Platelet C3G: a key player in vesicle exocytosis, spreading and clot retraction

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  6. Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma

    Clinical and Translational Oncology

  7. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

    Journal of Pathology, Vol. 263, Núm. 4-5, pp. 482-495

  8. Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  9. Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury

    International Journal of Biological Sciences, Vol. 20, Núm. 7, pp. 2339-2355

2023

  1. Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models

    Journal of Experimental and Clinical Cancer Research, Vol. 42, Núm. 1

  2. Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (197), 10.1186/s13046-023-02780-4)

    Journal of Experimental and Clinical Cancer Research

  3. Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma

    Redox Biology, Vol. 65

  4. Germline gain-of-function MMP11 variant results in an aggressive form of colorectal cancer

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 283-297

  5. Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetes

    Molecular and Cellular Endocrinology, Vol. 570

  6. Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth

    Acta Neurochirurgica, Vol. 165, Núm. 12, pp. 4241-4251

  7. New and Old Key Players in Liver Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  8. The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression

    Hepatology, Vol. 78, Núm. 2, pp. 416-433

2022

  1. A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2

    Journal of Clinical Medicine, Vol. 11, Núm. 11

  2. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma

    Matrix Biology, Vol. 111, pp. 207-225

  3. BMP9 Promotes an Epithelial Phenotype and a Hepatocyte-like Gene Expression Profile in Adult Hepatic Progenitor Cells

    Cells, Vol. 11, Núm. 3